Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2005
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618809A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618803A Recombinated phycobiliprotein and its preparation method and application
05/25/2005CN1618802A Tetramer combined with SARS antigen peptide and its preparation and use
05/25/2005CN1618344A Method for producing high ice-nuclear activity auxiliary freeze protein powder
05/25/2005CN1203185C Process for raising glutathion yield by fermentation of tornla yeast
05/25/2005CN1203184C Process for preparation of pseudomonic acid A antibiotic by microbiological method
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203179C DNA sequence and recombination production method of graminae allergen
05/25/2005CN1203171C Bacillus protein production cell
05/25/2005CN1203093C Method for producing whole silkworm powder milk-containing and ferritin
05/25/2005CA2448831A1 Multi-stage cascade boosting vaccine
05/24/2005US6897337 Labeling with methyl iodide
05/24/2005US6897292 For detecting a genetic abnormality, cancer
05/24/2005US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H
05/24/2005US6897063 Accessory functions for use in recombinant AAV virion production
05/24/2005US6897054 For controlling in vitro cell proliferation; genetic engineering
05/24/2005US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters
05/24/2005US6897040 Methods and host cells for improved cell culture
05/24/2005US6897039 For treatment of cardiovascular diseases.
05/24/2005US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in
05/24/2005US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/24/2005CA2037607C Humanised antibodies
05/24/2005CA1341484C Tissue plasminogen activator having zymogenic or fibrin specific properties
05/19/2005WO2005045045A2 Recombinant microorganism
05/19/2005WO2005045026A1 Insulin-expressing human islet cell lines capable of reversibly proliferating and use thereof
05/19/2005WO2005045013A2 Recombinant microorganism
05/19/2005WO2005045006A1 Microbe capable of producing dipeptide and process for producing dipeptide with the microbe
05/19/2005WO2005045005A1 Novel brevibacillus choshinensis and process for producing protein with use of the microbe as host
05/19/2005WO2005045001A2 Insulin-producing cells derived from stem cells
05/19/2005WO2005044979A2 Glycosylation enzymes and systems and methods of making and using them
05/19/2005WO2005044859A2 Cd20 antibodies with increased fc receptor binding affinity and effector function
05/19/2005WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
05/19/2005WO2005021764A3 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
05/19/2005WO2005021762A3 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
05/19/2005WO2005017093A8 Polypeptides of streptococcus pyogenes
05/19/2005WO2004045495A3 Interacting site for gp41 on gp120 of hiv-1
05/19/2005WO2004015125A9 Process for preparing peptides with anti-hypertensive properties
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003012035A3 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/19/2005US20050107597 Nucleotide sequences coding microorganismal secondary response gene (SPA-1) for as tool in diagnosis, prevention and treatment of pseudomonal infection
05/19/2005US20050107596 Immunoglobulin specific to kidney basement membrane protein for use in diagnosis, prevention and treatment of goodpasture syndrome
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050106703 Oligomerization of an amino acid or amino acid amide in presence of a microorganism of genus Escherichia, Bacillus, Corynebacterium or Saccharomyces in which the activities peptidases and proteins having peptide-transporting activity is reduced or lost
05/19/2005US20050106700 Using immobilized cohesin domains as affinity tools in recovery of dockerin polypeptides
05/19/2005US20050106682 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
05/19/2005US20050106680 Interferon-like protein Zcyto21
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106678 Human circulating cytokine CC-1
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106667 Variant complementary determining regions for use in identifying antigen binding polypeptides; mimetics; direceted protein evolution
05/19/2005US20050106664 Genetically engineered methylotrophic yeast for use as bioreactor in production of glycoproteins with mammalian-like glycosylation
05/19/2005US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106648 Immmunoglobulin specific to staphylococcal surface protein for use in diagnosis and prevention of bacterial infection; vaccine development; immunotherapy
05/19/2005US20050106642 Saliva test for early diagnosis of cancers
05/19/2005US20050106630 Building blocks for artificial receptors
05/19/2005US20050106628 MEGSIN protein
05/19/2005US20050106624 Concentrating low molecular weight peptides in the supernatant of serum-free cultured cells via cation exchangers; identifying tumor marker peptides and diagnosing cell proliferative disorders
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping
05/19/2005US20050106595 Expressed sequence tags and encoded human proteins
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050106222 Genetic engineering; gene expression; polypeptides
05/19/2005US20050106176 Vector reproduction using Dna polymerase; linking to chromosome; encoded as foreign gene; genetic engineering
05/19/2005US20050106149 Antibodies abolish prion propagation and remote clearance of infectivity
05/19/2005US20050106147 Method of promoting graft survival with anti-tissue factor antibodies
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/19/2005US20050106099 Fusion proteins
05/19/2005CA2548538A1 Compositions and methods of use for a fibroblast growth factor
05/19/2005CA2546083A1 Novel brevibacillus choshinensis and method for producing protein using the microorganism as host
05/19/2005CA2545166A1 Humanized anti-cd47 antibody
05/19/2005CA2544865A1 Cd20 antibodies with increased fc receptor binding affinity and effector function
05/19/2005CA2544807A1 Compositions and methods of using apoptosis signaling kinase related kinase (askrk)
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/19/2005CA2544207A1 Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
05/18/2005EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft
05/18/2005EP1530637A2 Subtilisin carlsberg proteins with reduced immunogenicity
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/18/2005EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/18/2005EP1161530B1 Protein for blocking platelet adhesion
05/18/2005EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3
05/18/2005EP0970187B1 Pituitary differentiation factor and methods of use thereof
05/18/2005EP0894141B1 Hybrid proteins which form heterodimers
05/18/2005EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth
05/18/2005CN1617930A Production of eukaryotic proteins and nucleic acid molecules in c. elegans
05/18/2005CN1617927A Pyroglutamyl peptidase and its gene
05/18/2005CN1617926A A structure for presenting desired peptide sequences
05/18/2005CN1617924A Method for large scale production of virus antigen
05/18/2005CN1617884A Beta-amyloid binding factors and inhibitors thereof
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 1125